Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
34.6x - 0.45x8.84x26.35x32.45x0.28% 5.55B
19.56x2.31x-3.66x4.52x13.37x14.11x0.51% 78.8B
29.76x4.19x2.61x5.93x17.14x21.56x0.54% 60.53B
39.28x7.86x0.77x12.96x23.72x28.2x-.--% 49.49B
35.29x2.46x-0.65x3.57x10.32x11.72x2.98% 47.58B
14.96x1.28x0.43x2.78x8.14x8.88x-.--% 25.99B
-7.33x3.21x1.99x7.9x-6.03x-5.81x-.--% 20.34B
79.54x7.65x-0.05x9.16x91.51x88.02x-.--% 19.43B
15.65x2.89x-4.7x2.53x8.08x7.56x-.--% 19.3B
23.89x3.34x0.02x4.83x13.16x19.25x-.--% 14.9B
-38.71x-6.22x0.8x17.49x-48.79x-57.5x-.--% 14.64B
74.24x29.4x0.85x38.19x51.9x52.89x0.09% 13.4B
13.1x - 0.09x3.11x13.55x24.78x-.--% 10.83B
-201.33x106.06x2.65x9.1x228.61x-206.63x-.--% 9.15B
33.1x - 2.35x - - - -.--% 7.6B
164.2x5.95x-2.92x - - - - 7.43B
5.08x1.97x0.01x2.16x3.22x3.27x3.68% 7.27B
-214.38x - 0.66x - - - -.--% 7.17B
11.09x1x0.31x1.78x7.13x9.42x2.19% 6.47B
Average 6.92x 11.56x 0.11x 8.43x 28.84x 3.26x 0.57% 22.41B
Weighted average by Cap. 19.65x 6.67x -0.26x 7.48x 20.84x 12.72x 0.62%
Biopharmaceuticals